Seeing Is Believing

Currently out of the existing stock ratings of Scott Henry, 75 are a BUY (82.42%), 16 are a HOLD (17.58%).
Analyst Scott Henry, currently employed at ALLIANCE GLOBAL PARTNERS, carries an average stock price target met ratio of 52.59% that have a potential upside of 49.27% achieved within 303 days. Previously, Scott Henry worked at ROTH.
Scott Henry’s has documented 180 price targets and ratings displayed on 33 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VVOS, Vivos Therapeutics at 18-Nov-2024.
Analyst best performing recommendations are on INVO (INVO BIOSCIENCE).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $124.77 was fulfilled within 1 day with a profit of $12.41 (11.04%) receiving and performance score of 110.45.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$121
$26.76 (28.40%)
$84
1 months 10 days ago
(16-Sep-2025)
4/5 (80%)
$25.64 (26.89%)
671
Buy
$114
$19.76 (20.97%)
$86
1 months 19 days ago
(07-Sep-2025)
10/11 (90.91%)
$18.8 (19.75%)
291
Hold
$77
$-17.24 (-18.29%)
$65
2 months 16 days ago
(10-Aug-2025)
10/11 (90.91%)
$-7.88 (-9.28%)
372
Buy
$94
$-0.24 (-0.25%)
$94
7 months 10 days ago
(16-Mar-2025)
13/13 (100%)
$29.65 (46.08%)
317
Buy
$83
$-11.24 (-11.93%)
$49
1 years 1 months 9 days ago
(17-Sep-2024)
12/12 (100%)
$21.95 (35.95%)
597
What Year was the first public recommendation made by Scott Henry?